查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493356

美國免疫測量市場規模、佔有率、趨勢分析報告：按產品、按技術、按應用、按檢體、按最終用途、按地區、細分市場預測，2024-2030 年

U.S. Immunoassay Market Size, Share & Trends Analysis Report By Product (Reagent & Kits, Analyzers/Instruments), By Technology (RIA, ELISA), By Application, By Specimen, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10個工作天內

價格

美國免疫測量市場的成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，美國免疫測量市場預計將達到122.5億美元，2024年至2030年的複合年成長率為2.8%。

慢性病和感染疾病患者的增加以及對疾病早期檢測的需求不斷增加是推動市場成長的主要因素。根據國際癌症研究機構的數據，2020年報告了19,292,789例癌症病例，預計2025年這一數字將達到50,550,287例。乳癌、肺癌、大腸癌、攝護腺癌和胃癌是最常見的癌症。

不斷成長的老年人口是推動美國市場成長的關鍵因素。隨著越來越多的人達到退休年齡並尋求醫療護理，對免疫測量等診斷測試的需求預計將會增加。此外，自動化、小型化、現場檢測設備和先進檢測技術等技術進步是免疫測量市場的關鍵促進因素。這些創新徹底改變了免疫測量技術，使其更有效率、可靠，並可在醫療保健和研究領域廣泛應用。

臨床診斷和研究實驗室擴大採用免疫測量測試，這對美國市場產生了積極影響，推動了市場擴張，推動了檢測法開發的創新，並透過早期準確的診斷改善了患者的治療結果。

美國免疫測量市場報告亮點

  • 到2023年，試劑和套件將以65.82%的收益佔有率引領市場，並且由於創新免疫測量套件的引進和批准不斷增加，預計在預測期內將以最快的複合年成長率成長。
  • 從應用來看，由於對 HIV、肝炎和 COVID-19 等感染疾病早期檢測的免疫測量的需求不斷增加，傳染病檢查領域將在 2023 年以 29.55% 的最大收益佔有率佔據市場主導地位。
  • 依最終用途分類，醫院領域佔市場佔有率最大，2023年銷售佔有率為33.01%。醫院被認為是診斷各種疾病的主要醫療機構，這正在推動該領域的成長。
  • 從檢體來看，血液細分市場在 2023 年以 43.19% 的最大收益佔有率引領市場。這是由於需要這些血液檢測程序的疾病發生率不斷增加以及該領域的技術進步。
  • 2023年7月，SEKISUI Diagnostics推出了美國製造的OSOM COVID-19抗原家庭檢驗。此測試可以在家中進行，可能有助於檢測 SARS-CoV-2 病毒引起的核衣殼蛋白抗原。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國免疫測量市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 美國免疫測量市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國免疫測量市場：產品評估與趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 按產品分類的美國免疫測量市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 試劑/套件
  • 分析儀/設備
  • 軟體服務

第5章美國免疫測量市場：技術評估與趨勢分析

  • 2023年及2030年技術市場佔有率
  • 細分儀表板
  • 按技術前景分類的美國免疫測量市場
  • 2018-2030年市場規模、預測及趨勢分析
  • 免疫測量
  • 酵素連結免疫測量
  • 快速測試
  • 其他

第6章美國免疫測量市場：應用估算與趨勢分析

  • 2023年及2030年應用市場佔有率
  • 細分儀表板
  • 美國免疫測量市場應用展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 治療藥物監測
  • 腫瘤學
  • 循環系統
  • 內分泌
  • 傳染病檢查
  • 自體免疫疾病
  • 其他

第7章美國免疫測量市場：最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的美國免疫測量市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院
  • 血庫
  • 臨床實驗室
  • 製藥和生物技術公司
  • 學術研究中心

第8章美國免疫測量市場：檢體估計與趨勢分析

  • 2023 年及 2030 年樣本市場佔有率
  • 細分儀表板
  • 美國標本免疫測量市場檢體
  • 2018-2030年市場規模、預測及趨勢分析
  • 血
  • 唾液
  • 尿
  • 其他檢體

第9章美國免疫測量市場：區域估計與趨勢分析

  • 2023 年和 2030 年按地區分類的市場佔有率佔有率
  • 美國免疫測量市場按地區展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 西
  • 中西部
  • 東北
  • 西南
  • 東南

第10章競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
  • 公司簡介
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Siemens Healthineers
    • Danaher Corporation
    • Thermo Fisher Scientific
    • Bio-Rad Laboratories
    • Beckman Coulter（a subsidiary of Danaher）
    • Sysmex Corporation
    • DiaSorin
    • Agilent Technologies
Product Code: GVR-4-68040-285-5

U.S. Immunoassay Market Growth & Trends:

The U.S. immunoassay market is anticipated to reach USD 12.25 billion by 2030 and is projected to grow at a CAGR of 2.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of chronic and infectious diseases and rising demand for early detection of diseases are the major factors contributing to the market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020 and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported.

The rising geriatric population is a significant factor driving the market growth in the U.S. As more individuals reach retirement age and require medical care, the demand for diagnostic tests such as immunoassays is expected to rise. Furthermore, technological advancements such as automation, miniaturization, point-of-care testing devices, and advanced detection technologies are key drivers of the immunoassay market. These innovations have revolutionized immunoassay techniques, making them more efficient, reliable, and accessible for a wide range of applications in healthcare and research.

The growing adoption of immunoassay tests in clinical diagnostics and research laboratories has positively impacted the U.S. market by driving market expansion, fostering innovation in assay development, and improving patient outcomes through early and accurate diagnosis.

U.S. Immunoassay Market Report Highlights:

  • Reagents & kits led the market with the largest revenue share of 65.82% in 2023 and are expected to grow at the fastest CAGR over the forecast period, owing to the increasing introduction and approval of innovative immunoassay kits
  • Based on application, the infectious diseases testing segment led the market with the largest revenue share of 29.55% in 2023, due to increasing demand for immunoassays for early detection of infectious diseases such as HIV, hepatitis, COVID-19, and others
  • Based on end-use, the hospital segments held the market with the largest revenue share of 33.01% in 2023. Hospitals are considered primary care facilities for the diagnosis of various diseases, which is driving segment growth
  • Based on specimen, the blood segment led the market with the largest revenue share of 43.19% in 2023, owing to the increasing incidence of diseases requiring these blood testing procedures and technological advancements in the segment
  • In July 2023, SEKISUI Diagnostics introduced the OSOM COVID-19 Antigen Home Test, made in the U.S. The test can be performed at home and is likely to help detect nucleocapsid protein antigen that results from the SARS-CoV-2 virus

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. End-use
    • 1.2.5. Specimen
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Application outlook
    • 2.2.4. End-use outlook
    • 2.2.5. Specimen outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Immunoassay Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Immunoassay Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape

Chapter 4. U.S. Immunoassay Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Immunoassay Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 4.4.1. Reagents & kits
      • 4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. ELISA reagents & kits
      • 4.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Rapid test reagents & kits
      • 4.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.4. ELISPOT reagents & kits
      • 4.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.5. Western blot reagents & kits
      • 4.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.6. Other reagents & kits
      • 4.4.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Analyzers/instruments
      • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.2. Open ended systems
      • 4.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.3. Closed ended systems
      • 4.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Software & Services
      • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Immunoassay Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Immunoassay Market by Technology Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 5.4.1. Radioimmunoassay (RIA)
      • 5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Enzyme Immunoassays (EIA)
      • 5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.2.2. Chemiluminescence Immunoassays (CLIA)
      • 5.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.2.3. Fluorescence Immunoassays (FIA)
      • 5.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Rapid test
      • 5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. U.S. Immunoassay Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Immunoassay Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 6.4.1. Therapeutic drug monitoring
      • 6.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Oncology
      • 6.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. Cardiology
      • 6.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.4. Endocrinology
      • 6.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.5. Infectious disease testing
      • 6.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.6. Autoimmune diseases
      • 6.4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.7. Others
      • 6.4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. U.S. Immunoassay Market: End-use Estimates & Trend Analysis

  • 7.1. End-use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. U.S. Immunoassay Market by End-use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 7.4.1. Hospitals
      • 7.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Blood banks
      • 7.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Clinical laboratories
      • 7.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Pharmaceutical and biotech companies
      • 7.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.5. Academic research centers
      • 7.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.6. Others
      • 7.4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. U.S. Immunoassay Market: Specimen Estimates & Trend Analysis

  • 8.1. Specimen Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. U.S. Immunoassay Market by Specimen Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 8.4.1. Blood
      • 8.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. Saliva
      • 8.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. Urine
      • 8.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. Other specimens
      • 8.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. U.S. Immunoassay Market: Region Estimates & Trend Analysis

  • 9.1. Regional Market Share, 2023 & 2030
  • 9.2. U.S. Immunoassay Market by Region Outlook
  • 9.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 9.3.1. West
      • 9.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.2. Midwest
      • 9.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.3. Northeast
      • 9.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.4. Southwest
      • 9.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.5. Southeast
      • 9.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company heat map analysis, 2023
  • 10.4. Company Profiles
    • 10.4.1. F. Hoffmann-La Roche AG
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Abbott Laboratories
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Siemens Healthineers
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Danaher Corporation
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Thermo Fisher Scientific
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Bio-Rad Laboratories
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Beckman Coulter (a subsidiary of Danaher)
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Sysmex Corporation
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. DiaSorin
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Agilent Technologies
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 4 U.S. immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. immunoassay market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 7 U.S. immunoassay market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. immunoassay market: Market outlook
  • Fig. 9 U.S. immunoassay competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. immunoassay market driver impact
  • Fig. 14 U.S. immunoassay market restraint impact
  • Fig. 15 U.S. immunoassay market: Product movement analysis
  • Fig. 16 U.S. immunoassay market: Product outlook and key takeaways
  • Fig. 17 Reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Elisa reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Rapid test reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Elispot reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Western blot reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Other reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Analyzers/Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Open ended systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Closed ended systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Software & services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. immunoassay Market: Technology movement Analysis
  • Fig. 28 U.S. immunoassay market: Technology outlook and key takeaways
  • Fig. 29 Radioimmunoassay (RIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Enzyme Immunoassays (EIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Chemiluminescence Immunoassays (CLIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Fluorescence Immunoassays (FIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Rapid test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. immunoassay market: Application movement analysis
  • Fig. 36 U.S. immunoassay market: Application outlook and key takeaways
  • Fig. 37 Therapeutic drug monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Endocrinology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Infectious disease testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Autoimmune diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. immunoassay market: End-use movement analysis
  • Fig. 45 U.S. immunoassay market: End-use outlook and key takeaways
  • Fig. 46 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Blood banks market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Pharmaceutical and biotech companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Academic research centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. immunoassay market: Specimen movement analysis
  • Fig. 53 U.S. immunoassay market: Specimen outlook and key takeaways
  • Fig. 54 Blood market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saliva market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Other specimens market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 U.S. immunoassay market: Regional movement analysis
  • Fig. 59 U.S. immunoassay market: Regional outlook and key takeaways
  • Fig. 60 West market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)